List of works - Andrew J Stevens

Adjusting for treatment refusal in rationing decisions

scientific article

Admissions processes for five year medical courses at English schools: review

scientific article

An investigation into general practitioners associated with high patient mortality flagged up through the Shipman inquiry: retrospective analysis of routine data

scientific article

Analyzing 10 years of early awareness and alert activity in the United kingdom.

scientific article published on July 2012

Assessing the accuracy of forecasting: applying standard diagnostic assessment tools to a health technology early warning system.

scientific article published in January 2004

At the center of health care policy making: the use of health technology assessment at NICE.

scientific article

Comment on: 'The cost of a QALY'

scientific article published on 28 October 2010

Commentary on drug-eluting stents: NICE technology appraisal guidance.

scientific article published on 3 September 2008

Decline in new drug launches: myth or reality? Retrospective observational study using 30 years of data from the UK

scientific article

Diffusion of thrombolysis for acute myocardial infarction from 1981 to 2000 in England: trend analysis and comparison with need

scientific article published on 01 January 2004

Effective early warning systems for new and emerging health technologies: developing an evaluation framework and an assessment of current systems.

scientific article published on January 2007

Evidence of methodological bias in hospital standardised mortality ratios: retrospective database study of English hospitals.

scientific article published on 18 March 2009

Has Calman-Hine succeeded? Analysis of breast cancer procedure loads per consultant firm before and after the Calman-Hine report

scientific article published on 01 February 2001

Health technology assessment: history and demand

article

Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis.

scientific article

Home-based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised c

scientific article

Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263]

scientific article

How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001-2012

scientific article

Identifying 'non-medical' datasets to monitor community health and well-being.

scientific article published in June 2001

Influences upon the diffusion of thrombolysis for acute myocardial infarction in England: case study

scientific article published on 01 January 2004

Innovation and the burden of disease: retrospective observational study of new and emerging health technologies reported by the EuroScan Network from 2000 to 2009.

scientific article published on 2 February 2012

Issues in methodological research: perspectives from researchers and commissioners.

scientific article

Lay conceptions of the ethical and scientific justifications for random allocation in clinical trials

scholarly article by Elizabeth J Robinson et al published February 2004 in Social Science and Medicine

Lay public's understanding of equipoise and randomisation in randomised controlled trials.

scientific article

Monitoring clinical trials--interim data should be publicly available

scientific article

More students, less capacity? An assessment of the competing demands on academic medical staff

scientific article published in December 2008

NICE guidance on axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment

scientific article published on 25 February 2015

NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib.

scientific article

NICE guidance on denosumab for prevention of skeletal-related events in adults with bone metastases from solid tumours

scientific article published on 01 December 2012

NICE guidance on panobinostat for patients with multiple myeloma after at least two previous treatments

scientific article published on 27 January 2016

NICE guidance on pazopanib for first-line treatment of advanced renal-cell carcinoma

scientific article published on 01 March 2011

NICE guidance on pixantrone monotherapy for multiply relapsed or refractory aggressive non-Hodgkin lymphoma

scientific article published on 01 April 2014

NICE guidance on rituximab for first-line treatment of symptomatic stage III-IV follicular lymphoma in previously untreated patients

scientific article published on 01 February 2012

NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer.

scientific article

National Institute for Health and Clinical Excellence appraisal and ageism ⬇️

scientific article published on 02 January 2012

Past speculations of the future: a review of the methods used for forecasting emerging health technologies

scientific article

Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom.

scientific article

Performance monitoring in Australia and England: from scandals to action

scientific article published on 01 November 2007

Pharmacoeconomics: NICE's approach to decision-making

scientific article

Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention: NICE technology appraisal guidance.

scientific article published on September 2010

Predicting the impact of new health technologies on average length of stay: development of a prediction framework.

scientific article

Prospective health impact assessment: pitfalls, problems, and possible ways forward ⬇️

scientific article published on November 17, 2001

Quantifying emerging drugs for very rare conditions

scientific article published on 01 May 2007

Randomisation in trials: do potential trial participants understand it and find it acceptable?

scientific article published on February 2004

Recruitment of ethnic minority patients to a cardiac rehabilitation trial: the Birmingham Rehabilitation Uptake Maximisation (BRUM) study [ISRCTN72884263].

scientific article

Rituximab for follicular non-Hodgkin lymphoma

scientific article published on 03 March 2008

Secular trends and evaluation of complex interventions: the rising tide phenomenon

scientific article published on 6 October 2015

Systems for routine information sharing in HTA. Working group 2 report

scientific article published on 01 January 2002

The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence.

scientific article published on September 2007

The NHS: assessing new technologies, NICE and value for money.

scientific article published in June 2011

The combined influence of distance and neighbourhood deprivation on Emergency Department attendance in a large English population: a retrospective database study

scientific article published on 16 July 2013

The ethics of placebo-controlled trials: a comparison of inert and active placebo controls.

scientific article

The findings of the Mid-Staffordshire Inquiry do not uphold the use of hospital standardized mortality ratios as a screening test for 'bad' hospitals ⬇️

scientific article published on May 7, 2013

The impact of describing clinical trial treatments as new or standard

scientific article published on 01 April 2004

Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981-2014: a retrospective observational study

scientific article

Use of health services by prison inmates: comparisons with the community

scientific article

Weekend admission to hospital has a higher risk of death in the elective setting than in the emergency setting: a retrospective database study of national health service hospitals in England.

scientific article

What are the relative merits of the sources used to identify potential research priorities for the NHS HTA programme?

scientific article published in January 2000

List of works by Andrew J Stevens

Adjusting for treatment refusal in rationing decisions

Admissions processes for five year medical courses at English schools: review

An investigation into general practitioners associated with high patient mortality flagged up through the Shipman inquiry: retrospective analysis of routine data

Analyzing 10 years of early awareness and alert activity in the United kingdom.

Assessing the accuracy of forecasting: applying standard diagnostic assessment tools to a health technology early warning system.

At the center of health care policy making: the use of health technology assessment at NICE.

Comment on: 'The cost of a QALY'

Commentary on drug-eluting stents: NICE technology appraisal guidance.

Decline in new drug launches: myth or reality? Retrospective observational study using 30 years of data from the UK

Diffusion of thrombolysis for acute myocardial infarction from 1981 to 2000 in England: trend analysis and comparison with need

Effective early warning systems for new and emerging health technologies: developing an evaluation framework and an assessment of current systems.

Evidence of methodological bias in hospital standardised mortality ratios: retrospective database study of English hospitals.

Has Calman-Hine succeeded? Analysis of breast cancer procedure loads per consultant firm before and after the Calman-Hine report

Health technology assessment: history and demand

Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis.

Home-based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised c

Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263]

How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001-2012

Identifying 'non-medical' datasets to monitor community health and well-being.

Influences upon the diffusion of thrombolysis for acute myocardial infarction in England: case study

Innovation and the burden of disease: retrospective observational study of new and emerging health technologies reported by the EuroScan Network from 2000 to 2009.

Issues in methodological research: perspectives from researchers and commissioners.

Lay conceptions of the ethical and scientific justifications for random allocation in clinical trials

Lay public's understanding of equipoise and randomisation in randomised controlled trials.

Monitoring clinical trials--interim data should be publicly available

More students, less capacity? An assessment of the competing demands on academic medical staff

NICE guidance on axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment

NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib.

NICE guidance on denosumab for prevention of skeletal-related events in adults with bone metastases from solid tumours

NICE guidance on panobinostat for patients with multiple myeloma after at least two previous treatments

NICE guidance on pazopanib for first-line treatment of advanced renal-cell carcinoma

NICE guidance on pixantrone monotherapy for multiply relapsed or refractory aggressive non-Hodgkin lymphoma

NICE guidance on rituximab for first-line treatment of symptomatic stage III-IV follicular lymphoma in previously untreated patients

NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer.

National Institute for Health and Clinical Excellence appraisal and ageism ⬇️

Past speculations of the future: a review of the methods used for forecasting emerging health technologies

Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom.

Performance monitoring in Australia and England: from scandals to action

Pharmacoeconomics: NICE's approach to decision-making

Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention: NICE technology appraisal guidance.

Predicting the impact of new health technologies on average length of stay: development of a prediction framework.

Prospective health impact assessment: pitfalls, problems, and possible ways forward ⬇️

Quantifying emerging drugs for very rare conditions

Randomisation in trials: do potential trial participants understand it and find it acceptable?

Recruitment of ethnic minority patients to a cardiac rehabilitation trial: the Birmingham Rehabilitation Uptake Maximisation (BRUM) study [ISRCTN72884263].

Rituximab for follicular non-Hodgkin lymphoma

Secular trends and evaluation of complex interventions: the rising tide phenomenon

Systems for routine information sharing in HTA. Working group 2 report

The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence.

The NHS: assessing new technologies, NICE and value for money.

The combined influence of distance and neighbourhood deprivation on Emergency Department attendance in a large English population: a retrospective database study

The ethics of placebo-controlled trials: a comparison of inert and active placebo controls.

The findings of the Mid-Staffordshire Inquiry do not uphold the use of hospital standardized mortality ratios as a screening test for 'bad' hospitals ⬇️

The impact of describing clinical trial treatments as new or standard

Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981-2014: a retrospective observational study

Use of health services by prison inmates: comparisons with the community

Weekend admission to hospital has a higher risk of death in the elective setting than in the emergency setting: a retrospective database study of national health service hospitals in England.

What are the relative merits of the sources used to identify potential research priorities for the NHS HTA programme?